Dynamics of mortality from breast cancer in the regional context of 2014–2023
https://doi.org/10.47093/2713-069X.2025.6.4.35-44
Abstract
Breast cancer (BC) is the most common type of cancer among women worldwide.
Aim. The objective is to assess the dynamics of regional standardized death rates (SDR) from breast cancer among women in Russian regions over a tenyear period, including taking into account the COVID-19 pandemic.
Materials and methods. Rosstat data for 2014–2023 on the average annual population and the number of deaths in one-year age groups in the constituent entities of the Russian Federation. The calculations were performed using the computer program “Calculation and analysis of mortality rates and years of life lost due to premature mortality in the constituent entities of the Russian Federation”.
Results. In general, in Russia, the SDR from breast cancer among women decreased annually, and decreased by 16.7 % over 10 years. In 5-year age groups, mortality rates under 80 decreased, but increased at the age of over 80 (in 2020–2022 compared to 2019). The average regional SDR was 21.17 ± 3.87 per 100 thousand women in 2019 and 17.19 ± 3.04 in 2023. In 2023, the SDR was lower in 75 regions than in 2014, but an annual decrease in the SDR compared to 2014 was noted only in 26 regions (in the rest, unstable dynamics). The region in which the SDR from breast cancer was higher annually than in 2014 is the Novgorod region. The increase in SDR in 2020 against the backdrop of the COVID-19 pandemic compared to 2019 occurred in 28 regions and in 4 regions the SDR from breast cancer in 2023 was higher than in 2019.
Conclusions. In most regions over a ten-year period, the SDR from breast cancer decreased, the COVID-19 pandemic led to a small short-term increase in SDR in some regions.
About the Authors
E. P. Kakorina
Moscow Regional Research Clinical Institute named after V.F. Vladimirsky
Россия
Россия
Ekaterina P. Kakorina – Dr. of Sci. (Medicine), Professor, Deputy Director
Shchepkina str., 62/1, Moscow, 129110
I. V. Samorodskaya
Moscow Regional Research Clinical Institute named after V.F. Vladimirsky
Россия
Россия
Irina V. Samorodskaya – Dr. of Sci. (Medicine), Professor
Shchepkina str., 62/1, Moscow, 129110
References
1. Storme G.A. Breast Cancer: Impact of New Treatments? Cancers (Basel). 2023; 15(8): 2205. https://doi.org/10.3390/cancers15082205. PMID: 37190134
2. Caswell-Jin J.L., Sun L.P., Munoz D., et al. Analysis of Breast Cancer Mortality in the US-1975 to 2019. JAMA. 2024; 331(3): 233–241. https://doi.org/10.1001/jama.2023.25881. PMID: 38227031
3. Wojtyla C., Bertuccio P., Wojtyla A., La Vecchia C. European trends in breast cancer mortality, 1980-2017 and predictions to 2025. Eur J Cancer. 2021; 152: 4–17. https://doi.org/10.1016/j.ejca.2021.04.026PMID: 34062485
4. Katsika L., Boureka E., Kalogiannidis I., et al. Screening for Breast Cancer: A Comparative Review of Guidelines. Life (Basel). 2024; 14 (6): 777. https://doi.org/10.3390/life14060777. PMID: 38929759
5. Kakorina E.P., Beresten N.F. Breast cancer: some approaches to solving problems. Healthcare. 2011; 11: 32–39 (In Russian). EDN: QBHMWB
6. Manikhas G., Safronova O., Punanova N. Mammographic screening: the history of development, formation, results. Doctor. 2015; 12: 75–78 (In Russian). EDN: VCOQHT
7. Shakhzadova A.O., Starinsky V.V., Lisichnikova I.V. Methodological approaches to assessing incidence, survival, and mortality rates in breast cancer in the Russian Federation. P.A. Herzen Journal of Oncology. 2024; 13(1): 36–43 (In Russian). https://doi.org/10.17116/onkolog20241301136. EDN: NCTYWK
8. Malignant tumors in Russia in 2023 (morbidity and mortality). Ed. A.D. Kaprina, V.V. Starinskogo, A.O. Shakhzadovoi. Moscow: P. Herzen MORI, 2024. 274 p. (In Russian). ISBN 978-5-85502-290-2.
9. Breusov A.V., Ryzhova A.S. Breast cancer: incidence and mortality in the Kursk and Bryansk regions in 2011–2020. Scientific electronic journal Meridian. 2021: 4(57): 39–41 (In Russian). EDN: YONIRD
10. Petrova G.V., Gretsova O.P. Malignant neoplasms in Russia in 2014 (morbidity and mortality): monograph. Moscow: P. Herzen MORI, 2016. 250 p. (In Russian). ISBN 978-5-85502-219-3. EDN: ZUPCCP
11. Zaikova Z.A., Kravchenko N.A. Breast cancer: morbidity and mortality statistics. Yakut Medical Journal. 2023; 3: 72–75 (In Russian). https://doi.org/10.25789/YMJ.2023.83.18. EDN: DIBYZI
12. Merabishvili V.M. The state of cancer care in Russia: breast cancer among the female population. Morbidity, mortality, index of accuracy, detailed localization and histological structure (population study at the federal district level). Voprosy Onkologii. 2022; 68(3): 286–293 (In Russian). https://doi.org/10.37469/0507-3758-2022-68-3-286-293. EDN: SLCVWU
13. Long Z., Qiu Y., Long Z., Jin Z. Epidemiology of breast cancer in Chinese women from 1990 to 2021: a systematic analysis and comparison with the global burden. BMC Cancer. 2025; 25(3): 1–10. https://doi.org/10.1186/s12885-024-13336-w. PMID: 39757149
14. Zhang X., Elsaid M., DeGraffinreid C., et al. Impact of the COVID-19 Pandemic on Cancer Screening Delays. Journal of Clinical Oncology. 2023; 41(17): 3194–3202. https://doi.org/10.1200/JCO.22.01704. PMID: 36735899
15. Norman E.S. COVID-19 and cancer. Science. 2020; 368(6497): 1290. https://doi.org/10.1126/science.abd3377. PMID: 32554570
16. Bardet A., Fraslin A.M., Marghadi J., et al. Impact of COVID-19 on healthcare organisation and cancer outcomes. Eur J Cancer. 2021; 153: 123–132. https://doi.org/10.1016/j.ejca.2021.05.012. PMID: 3415371
17. Maringe C., Spicer J., Morris M., et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. The Lancet Oncology. 2020; 21(8): 1023–1034. https://doi.org/10.1016/S1470-2045(20)30388-0
18. Lohfeld L., Sharma M., Bennett D., et al. Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland – a scoping review. Br J Cancer. 2024; 131(4): 619–626. https://doi.org/10.1038/s41416-024-02703-w. PMID: 38704477
19. Negoita S.I., Ionescu R.V., Zlati M.L., et al. New Regional Dynamic Cancer Model across the European Union. Cancers (Basel). 2023; 15(9): 2545. https://doi.org/10.3390/cancers15092545. PMID: 37174011
20. Ciuba A., Wnuk K., Nitsch-Osuch A., Kulpa M. Health Care Accessibility and Breast Cancer Mortality in Europe. International Journal of Environmental Research and Public Health. 2022; 19(20): 13605. https://doi.org/10.3390/ijerph192013605. PMID: 36294189
21. De Glas N., Bastiaannet E., de Boer A., et al. Improved survival of older patients with advanced breast cancer due to an increase in systemic treatments: a population-based study. Breast Cancer Res Treat. 2019; 178(1): 141–149. https://doi.org/10.1007/s10549-019-05356-z. PMID: 31325075
22. Autier P., Jørgensen K.J., Smans M., Støvring H. Effect of screening mammography on the risk of breast cancer deaths and of all-cause deaths: a systematic review with meta-analysis of cohort studies. J Clin Epidemiol. 2024; 172: 111426. https://doi.org/10.1016/j.jclinepi.2024.111426. PMID: 38878837
23. Duffy S., Vulkan D., Cuckle H., et al. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Health Technol Assess. 2020; 24(55): 1–24. https://doi.org/10.3310/hta24550. PMID: 33141657
24. Dibden A., Offman J., Duffy S.W., Gabe R. Worldwide Review and Meta-Analysis of Cohort Studies Measuring the Effect of Mammography Screening Programmes on Incidence-Based Breast Cancer Mortality. Cancers (Basel). 2020; 12(4): 976. https://doi.org/10.3390/cancers12040976
25. Arık A., Cairns A.J.G., Dodd E., et al. The effect of the COVID-19 health disruptions on breast cancer mortality for older women: a semi-Markov modelling approach. Scandinavian Actuarial Journal. 2024; 8: 848–879. https://doi.org/10.1080/03461238.2024.2340964
26. Eijkelboom A.H., De Munck L., Larsen M., et al. Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study. Cancer Epidemiol. 2023; 87: 102481. https://doi.org/10.1016/j.canep.2023.102481. PMID: 37897970
27. Da Cunha A.R., Antunes J.L.F. Impact of the COVID-19 pandemic on cancer mortality in Brazil. BMC Cancer. 2024; 24(1): 1125. https://doi.org/10.1186/s12885-024-12761-1. PMID: 39256699
28. Contiero P., Boffi R., Borgini A., et al. Causes of death in women with breast cancer: a risks and rates. Front Oncol. 2023; 13: 1270877. https://doi.org/10.3389/fonc.2023.1270877
29. Drapkina O.M., Samorodskaya I.V., Kakorina E.P., Semenov V.Yu. COVID-19 and regional mortality in the Russian Federation. Russian Journal of Preventive Medicine. 2021; 24(7): 14–21 (In Russian). https://doi.org/10.17116/profmed20212407114
30. Smirnova M.I., Samorodskaya I.V., Drapkina OM. Variability of death rates from respiratory diseases in the regions of the Russian Federation during the COVID-19 pandemic and the three previous years. Russian Journal of Preventive Medicine. 2024; 27(4): 82–88 (In Russian). https://doi.org/10.17116/profmed20242704182
31. O’Driscoll J., Mooney T., Kearney P., et al. Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland. J Med Screen. 2024; 31(3): 182–190. https://doi.org/10.1177/09691413241232899. PMID: 38509806
Review
For citations:
Kakorina E.P., Samorodskaya I.V. Dynamics of mortality from breast cancer in the regional context of 2014–2023. National Health Care (Russia). 2025;6(4):35-44. (In Russ.) https://doi.org/10.47093/2713-069X.2025.6.4.35-44
Views:
109
JATS XML
Email this article 